Bridging the Gap Between Sorafinib Efficacy and Effectiveness in Advanced Hepatocellular Carcinoma
View/ Open
Published Version
https://doi.org/10.1634/theoncologist.2016-0349Metadata
Show full item recordCitation
Nipp, Ryan, and Lipika Goyal. 2016. “Bridging the Gap Between Sorafinib Efficacy and Effectiveness in Advanced Hepatocellular Carcinoma.” The Oncologist 21 (11): 1283-1285. doi:10.1634/theoncologist.2016-0349. http://dx.doi.org/10.1634/theoncologist.2016-0349.Abstract
In this editorial, the generalizability of trial results to the geriatric population is discussed. Specifically, the results from a recent observational study are compared with results from the SHARP trial, and recommendations are made for bridging the gap between efficacy and effectiveness in clinical research, particularly with regard to older patients.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189629/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29738965
Collections
- HMS Scholarly Articles [17928]
Contact administrator regarding this item (to report mistakes or request changes)